Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells
出版年份 2019 全文链接
标题
Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells
作者
关键词
-
出版物
Cells
Volume 8, Issue 1, Pages 74
出版商
MDPI AG
发表日期
2019-01-22
DOI
10.3390/cells8010074
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Treatment with docetaxel in combination with Aneustat leads to potent inhibition of metastasis in a patient-derived xenograft model of advanced prostate cancer
- (2018) Sifeng Qu et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Heterochromatin Protein 1α Mediates Development and Aggressiveness of Neuroendocrine Prostate Cancer
- (2018) Xinpei Ci et al. CANCER RESEARCH
- Analysis of cabazitaxel-resistant mechanism in human castration-resistant prostate cancer
- (2018) Hiroshi Hongo et al. CANCER SCIENCE
- Establishment of a Patient-Derived Tumor Xenograft Model and Application for Precision Cancer Medicine
- (2018) Seiji Okada et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer
- (2018) Jun Hao et al. EUROPEAN UROLOGY
- Moving Towards Precision Urologic Oncology: Targeting Enzalutamide-resistant Prostate Cancer and Mutated Forms of the Androgen Receptor Using the Novel Inhibitor Darolutamide (ODM-201)
- (2018) Hendrik Borgmann et al. EUROPEAN UROLOGY
- Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer
- (2018) Fan Mo et al. EUROPEAN UROLOGY
- Patient derived organoids to model rare prostate cancer phenotypes
- (2018) Loredana Puca et al. Nature Communications
- Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines
- (2018) Kazuaki Machioka et al. Oncotarget
- Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy
- (2018) Mitchell G. Lawrence et al. EUROPEAN UROLOGY
- Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models
- (2018) Nora M. Navone et al. PROSTATE
- A novel selenonucleoside suppresses tumor growth by targeting Skp2 degradation in paclitaxel-resistant prostate cancer
- (2018) Woong Sub Byun et al. BIOCHEMICAL PHARMACOLOGY
- Patient-derived, three-dimensional spheroid cultures provide a versatile translational model for the study of organ-confined prostate cancer
- (2018) Johannes Linxweiler et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Neuroendocrine differentiation of prostate cancer leads to PSMA suppression
- (2018) Martin K Bakht et al. ENDOCRINE-RELATED CANCER
- Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer
- (2017) Chengfei Liu et al. MOLECULAR CANCER THERAPEUTICS
- Combination Treatment with Orlistat-Containing Nanoparticles and Taxanes Is Synergistic and Enhances Microtubule Stability in Taxane-Resistant Prostate Cancer Cells
- (2017) Joshua J. Souchek et al. MOLECULAR CANCER THERAPEUTICS
- The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer
- (2017) Karen Hanrahan et al. Molecular Oncology
- Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
- (2017) Loren M. Lasko et al. NATURE
- LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease and Serve as Models for Evaluating Cancer Therapeutics
- (2017) Holly M. Nguyen et al. PROSTATE
- The 22Rv1 prostate cancer cell line carries mixed genetic ancestry: Implications for prostate cancer health disparities research using pre-clinical models
- (2017) Leanne Woods-Burnham et al. PROSTATE
- Modeling Development and Disease with Organoids
- (2016) Hans Clevers CELL
- Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived Xenografts
- (2016) Hung-Ming Lam et al. CLINICAL CANCER RESEARCH
- Defining a Population of Stem-like Human Prostate Cancer Cells That Can Generate and Propagate Castration-Resistant Prostate Cancer
- (2016) X. Chen et al. CLINICAL CANCER RESEARCH
- Differentially methylated genes and androgen receptor re-expression in small cell prostate carcinomas
- (2016) Brittany Kleb et al. Epigenetics
- Downregulation of cytokeratin 18 is associated with paclitaxel-resistance and tumor aggressiveness in prostate cancer
- (2016) BO YIN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Androgen-induced Long Noncoding RNA (lncRNA)SOCS2-AS1Promotes Cell Growth and Inhibits Apoptosis in Prostate Cancer Cells
- (2016) Aya Misawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- US cancer institute to overhaul tumour cell lines
- (2016) Heidi Ledford NATURE
- Organoid culture systems for prostate epithelial and cancer tissue
- (2016) Jarno Drost et al. Nature Protocols
- Skp2 is associated with paclitaxel resistance in prostate cancer cells
- (2016) YEGUO YANG et al. ONCOLOGY REPORTS
- Up-Regulation of Follistatin-Like 1 By the Androgen Receptor and Melanoma Antigen-A11 in Prostate Cancer
- (2016) Shifeng Su et al. PROSTATE
- Evidence for Feedback Regulation Following Cholesterol Lowering Therapy in a Prostate Cancer Xenograft Model
- (2016) Elizabeth M. Masko et al. PROSTATE
- The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer
- (2016) Jennifer L. Bishop et al. Cancer Discovery
- BAY 1024767 blocks androgen receptor mutants found in castration-resistant prostate cancer patients
- (2016) Tatsuo Sugawara et al. Oncotarget
- Establishment and Characterization of an In Vitro Model of Ovarian Cancer Stem-like Cells with an Enhanced Proliferative Capacity
- (2015) T. Ishiguro et al. CANCER RESEARCH
- Organoid Models of Human and Mouse Ductal Pancreatic Cancer
- (2015) Sylvia F. Boj et al. CELL
- SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer
- (2015) X. Zhang et al. CLINICAL CANCER RESEARCH
- Organoid development in cancer genome discovery
- (2015) Dong Gao et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- The Upregulation of PI3K/Akt and MAP Kinase Pathways is Associated with Resistance of Microtubule-Targeting Drugs in Prostate Cancer
- (2015) Zhi Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Establishment of primary patient-derived xenografts of palliative TURP specimens to study castrate-resistant prostate cancer
- (2015) Mitchell G. Lawrence et al. PROSTATE
- TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression
- (2015) Ken-ichi Takayama et al. Nature Communications
- Development and exploitation of a novel mutant androgen receptor modelling strategy to identify new targets for advanced prostate cancer therapy
- (2015) Daniel O’Neill et al. Oncotarget
- PVT1 Exon 9: A Potential Biomarker of Aggressive Prostate Cancer?
- (2015) Adeodat Ilboudo et al. International Journal of Environmental Research and Public Health
- Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer
- (2014) Maria Thadani-Mulero et al. CANCER RESEARCH
- Cancer Cell Lines for Drug Discovery and Development
- (2014) J. L. Wilding et al. CANCER RESEARCH
- Organoid Cultures Derived from Patients with Advanced Prostate Cancer
- (2014) Dong Gao et al. CELL
- Aberrant Presentation of HPA-Reactive Carbohydrates Implies Selectin-Independent Metastasis Formation in Human Prostate Cancer
- (2014) T. Lange et al. CLINICAL CANCER RESEARCH
- Establishment and Characterization of a Highly Tumorigenic African American Prostate Cancer Cell Line, E006AA-hT
- (2014) Shahriar Koochekpour et al. International Journal of Biological Sciences
- Neuroendocrine Prostate Cancer (NEPC) Progressing From Conventional Prostatic Adenocarcinoma: Factors Associated With Time to Development of NEPC and Survival From NEPC Diagnosis—A Systematic Review and Pooled Analysis
- (2014) Hai Tao Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- Secretome Analysis of an Osteogenic Prostate Tumor Identifies Complex Signaling Networks Mediating Cross-talk of Cancer and Stromal Cells Within the Tumor Microenvironment
- (2014) Yu-Chen Lee et al. MOLECULAR & CELLULAR PROTEOMICS
- Hydrogel-Based 3D Model of Patient-Derived Prostate Xenograft Tumors Suitable for Drug Screening
- (2014) Eliza L. S. Fong et al. MOLECULAR PHARMACEUTICS
- Genome sequencing of normal cells reveals developmental lineages and mutational processes
- (2014) Sam Behjati et al. NATURE
- Targeting Poly(ADP-Ribose) Polymerase and the c-Myb-Regulated DNA Damage Response Pathway in Castration-Resistant Prostate Cancer
- (2014) L. Li et al. Science Signaling
- High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development
- (2013) D. Lin et al. CANCER RESEARCH
- CCR1/CCL5 interaction promotes invasion of taxane-resistant PC3 prostate cancer cells by increasing secretion of MMPs 2/9 and by activating ERK and Rac signaling
- (2013) Taku Kato et al. CYTOKINE
- Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer
- (2013) Ken-ichi Takayama et al. EMBO JOURNAL
- The BALB/c-specific polymorphic SIRPA enhances its affinity for human CD47, inhibiting phagocytosis against human cells to promote xenogeneic engraftment
- (2013) Chika Iwamoto et al. EXPERIMENTAL HEMATOLOGY
- A Novel Antiandrogen, Compound 30, Suppresses Castration-Resistant and MDV3100-Resistant Prostate Cancer Growth In Vitro and In Vivo
- (2013) H. Kuruma et al. MOLECULAR CANCER THERAPEUTICS
- A preclinical xenograft model of prostate cancer using human tumors
- (2013) Mitchell G Lawrence et al. Nature Protocols
- Ex vivo culture of human prostate tissue and drug development
- (2013) Margaret M. Centenera et al. Nature Reviews Urology
- Induction of the Stem-like Cell Regulator CD44 by Rho Kinase Inhibition Contributes to the Maintenance of Colon Cancer-Initiating Cells
- (2012) H. Ohata et al. CANCER RESEARCH
- Human Prostate Cancer in a Clinically Relevant Xenograft Mouse Model: Identification of β(1,6)-Branched Oligosaccharides as a Marker of Tumor Progression
- (2012) Tobias Lange et al. CLINICAL CANCER RESEARCH
- The Promise of Patient-Derived Xenografts: The Best Laid Plans of Mice and Men
- (2012) S. Kopetz et al. CLINICAL CANCER RESEARCH
- Acquisition of paclitaxel resistance is associated with a more aggressive and invasive phenotype in prostate cancer
- (2012) John J. Kim et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- TACC2 Is an Androgen-Responsive Cell Cycle Regulator Promoting Androgen-Mediated and Castration-Resistant Growth of Prostate Cancer
- (2012) Ken-ichi Takayama et al. MOLECULAR ENDOCRINOLOGY
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression
- (2012) Y Li et al. ONCOGENE
- Chemoresistance in Prostate Cancer Cells Is Regulated by miRNAs and Hedgehog Pathway
- (2012) Saurabh Singh et al. PLoS One
- ETS1 promotes chemoresistance and invasion of paclitaxel-resistant, hormone-refractory PC3 prostate cancer cells by up-regulating MDR1 and MMP9 expression
- (2011) Taku Kato et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Intragenic Rearrangement and Altered RNA Splicing of the Androgen Receptor in a Cell-Based Model of Prostate Cancer Progression
- (2011) Y. Li et al. CANCER RESEARCH
- Modeling a Lethal Prostate Cancer Variant with Small-Cell Carcinoma Features
- (2011) V. Tzelepi et al. CLINICAL CANCER RESEARCH
- Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
- (2011) Toshiro Sato et al. GASTROENTEROLOGY
- Resistance to paclitaxel increases the sensitivity to other microenvironmental stresses in prostate cancer cells
- (2011) Youqiang Li et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Characterisation and manipulation of docetaxel resistant prostate cancer cell lines
- (2011) Amanda J O'Neill et al. Molecular Cancer
- Identification of Docetaxel Resistance Genes in Castration-Resistant Prostate Cancer
- (2011) M. Marin-Aguilera et al. MOLECULAR CANCER THERAPEUTICS
- Modulation of Androgen Receptor Signaling in Hormonal Therapy-Resistant Prostate Cancer Cell Lines
- (2011) Rute B. Marques et al. PLoS One
- PC3 is a cell line characteristic of prostatic small cell carcinoma
- (2011) Sheng Tai et al. PROSTATE
- Brief Report: A Bioassay to Identify Primary Human Prostate Cancer Repopulating Cells
- (2011) Roxanne Toivanen et al. STEM CELLS
- Paclitaxel- and lapatinib-loaded lipopolymer micelles overcome multidrug resistance in prostate cancer
- (2011) Feng Li et al. Drug Delivery and Translational Research
- Identification of EP4 as a Potential Target for the Treatment of Castration-Resistant Prostate Cancer Using a Novel Xenograft Model
- (2010) N. Terada et al. CANCER RESEARCH
- Androgen-responsive and -unresponsive prostate cancer cell lines respond differently to stimuli inducing neuroendocrine differentiation
- (2010) S. Marchiani et al. INTERNATIONAL JOURNAL OF ANDROLOGY
- MiR-148a Attenuates Paclitaxel Resistance of Hormone-refractory, Drug-resistant Prostate Cancer PC3 Cells by Regulating MSK1 Expression
- (2010) Yasunori Fujita et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient's tumor: Morphological, immunohistochemical, and gene expression profiles
- (2010) Ana Aparicio et al. PROSTATE
- MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms
- (2010) Keitaro Kojima et al. PROSTATE
- Expression of HLA-like structures on a permanent human tumor line PC-93
- (2010) Frans H. J. Claas et al. TISSUE ANTIGENS
- A Primary Xenograft Model of Small-Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by Culture In vitro
- (2009) V. C. Daniel et al. CANCER RESEARCH
- Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
- (2009) Toshiro Sato et al. NATURE
- Antiandrogen withdrawal syndrome and alternative antiandrogen therapy associated with the W741C mutant androgen receptor in a novel prostate cancer xenograft
- (2009) Naoki Terada et al. PROSTATE
- CTEN/tensin 4 expression induces sensitivity to paclitaxel in prostate cancer
- (2009) YouQiang Li et al. PROSTATE
- Clusterin knockdown using the antisense oligonucleotide OGX-011 re-sensitizes docetaxel-refractory prostate cancer PC-3 cells to chemotherapy
- (2008) Richard D. Sowery et al. BJU INTERNATIONAL
- Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer
- (2008) W M van Weerden et al. BRITISH JOURNAL OF CANCER
- Splicing of a Novel Androgen Receptor Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy Resistance
- (2008) S. M. Dehm et al. CANCER RESEARCH
- CD44 expression is a feature of prostatic small cell Carcinoma and Distinguishes it from its Mimickers
- (2008) Rochelle A. Simon et al. HUMAN PATHOLOGY
- Androgen receptor–negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms
- (2008) Zhi Gang Li et al. JOURNAL OF CLINICAL INVESTIGATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now